Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Enzene First in India for Virtuosi®
  • USA - English


News provided by

Quality Executive Partners, Inc.

08 Oct, 2025, 12:00 IST

Share this article

Share toX

Share this article

Share toX

Enzene is a fully integrated, end-to-end, continuously innovative development and manufacturing organization (CIDMO) with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA).
Enzene is a fully integrated, end-to-end, continuously innovative development and manufacturing organization (CIDMO) with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA).
Virtuosi is powered by Quality Executive Partners, Inc., a leading technical, compliance and business consulting firm for the pharmaceutical industry. Virtuosi is your validated, pharmaceutical education tool firmly rooted in Sterility Assurance, Microbiology and Cell and Gene Therapy content. This training program decreases time to competency and human error to increase your bottom line.
Virtuosi is powered by Quality Executive Partners, Inc., a leading technical, compliance and business consulting firm for the pharmaceutical industry. Virtuosi is your validated, pharmaceutical education tool firmly rooted in Sterility Assurance, Microbiology and Cell and Gene Therapy content. This training program decreases time to competency and human error to increase your bottom line.

PUNE, India, Oct. 8, 2025 /PRNewswire/ -- Enzene Biosciences Ltd., a leading Continuously Innovative Development and Manufacturing Organization (CIDMO) in the biologics industry, today announced its strategic partnership with Virtuosi®, the world's first IACET-accredited immersive training platform for pharmaceutical manufacturing, developed by Quality Executive Partners, Inc. (QxP). With this collaboration, Enzene becomes the first Indian company to partner with Virtuosi in support of developing a fully skilled, globally competitive pharmaceutical workforce.

As India's pharmaceutical sector continues its rapid growth, driven by innovation in biologics and biosimilars, the demand for highly trained professionals has never been greater. Virtuosi provides a scalable, interactive learning platform that leverages virtual reality (VR), digital simulation, and accredited technical curricula to strengthen workforce capabilities across critical areas such as aseptic processing, quality assurance, data integrity, and regulatory compliance.

"At Enzene, we believe that investing in our people and cultivating a highly skilled workforce are fundamental to earning our place as a trusted global pharmaceutical leader," said Sundar Ramanan, PhD, Chief Quality Officer. "By partnering with Virtuosi, we are investing not only in training excellence for our own teams, but also in setting a benchmark for the entire industry. This is about raising the standard for how medicines are made—safely, compliantly, and with world-class technical mastery."

"Enzene's leadership demonstrates vision and commitment at a time when the global industry is calling for stronger workforce readiness," said Crystal Mersh, Chief Executive Officer and Founder of Quality Executive Partners. "As the first global company to implement Virtuosi in India, Enzene signals a new era of manufacturing excellence—showcasing that India's CIDMO sector is not only scaling capacity, but also investing in the people and knowledge needed to sustain excellence. Enzene is leading the way."

The partnership marks a significant milestone in bridging innovation with education, as Enzene integrates Virtuosi into its workforce development programs. This collaboration reflects Enzene's dedication to fostering a culture of continuous learning, while reinforcing India's position at the forefront of global pharmaceutical manufacturing.

About Enzene

Enzene is a fully integrated, end-to-end, continuously innovative development and manufacturing organization (CIDMO) with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA). As a pioneer in next-generation biologics technologies, Enzene is disrupting the existing biologics manufacturing paradigm with its patented EnzeneX™ technology, which was the first fully-connected continuous manufacturing™ (FCCM™) platform validated for commercial biologics supply.

We partner with innovators and biosimilar developers to deliver accelerated time-to-market, increased production yields, and cost reductions across a broad range of biologic modalities. Committed to pushing the boundaries of biologics manufacturing innovation, Enzene is striving to reduce monoclonal antibody production costs to below $40 per gram by 2025.

For more information on Enzene, please visit www.enzene.com

About Virtuosi

Virtuosi, developed by Quality Executive Partners, Inc. (QxP), is the world's first IACET-accredited interactive training platform for the pharmaceutical industry. Combining interactive virtual reality with expert-driven curricula, Virtuosi equips professionals with practical skills, regulatory knowledge, and critical thinking capabilities required for today's advanced manufacturing environments. Virtuosi contains 100 hours of content and 26 virtual reality segments to solidify your employees' learning in aseptic processing, microbiology and cell & gene therapy.  As a global provider, Virtuosi is available in 7 different languages and can be adapted to meet your needs locally.

For more information about Virtuosi, please visit www.virtuosivr.com

About Quality Executive Partners, Inc. (QxP)

Quality Executive Partners, Inc. (QxP) is a cGMP consulting and technology firm, providing the life sciences industry with tomorrow's innovative solutions, tailored to meet the most daunting technical challenges of today.  We were founded in 2012 to disrupt the traditional Life Sciences GMP consulting model.  We have one of the most experienced and highly regarded teams in the pharmaceutical industry, recognized for their unparalleled remediation results and technical capabilities. 

The mission of QxP is to ensure our clients meet their business, quality, and compliance goals simultaneously.  We achieve this through a unique partnering relationship that provides unmatched management and technical expertise, educational tools, mentoring, and execution support.  Our success is defined by providing timely delivery of those goals coupled with the transfer of knowledge and capability to the client's team. 

For more information on QxP, please visit www.qualityexecutivepartners.com

Contact:
Christine Feaster 
1-443-752-7070 
[email protected]

Logo - https://mma.prnewswire.com/media/2790800/Enzene_Logo.jpg

Logo - https://mma.prnewswire.com/media/2790799/Virtuosi_Logo.jpg

Modal title

Also from this source

Virtuosi® 2.0 - जारी किया गया

Virtuosi® 2.0 - जारी किया गया

Quality Executive Partners (QxP) ने आज Virtuosi 2.0 के लॉन्च की घोषणा की है। यह उन्नत मैन्यूफ़ैक्चरिंग युग के लिए उन्नत GMP शिक्षा है। Virtuosi दवा और ...

Virtuosi® 2.0 - Unleashed

Virtuosi® 2.0 - Unleashed

Quality Executive Partners (QxP) today announced the launch of Virtuosi 2.0. This is enhanced GMP Education for the Advanced Manufacturing Era....

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Licensing

Licensing

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.